Sökresultat - Isaacs, John D.

Antibody engineering to develop new antirheumatic therapies av Isaacs, John D

Hämta fulltext Hämta fulltext Hämta fulltext

Tolerising cellular therapies: what is their promise for autoimmune disease? av Mosanya, Chijioke H, Isaacs, John D

Hämta fulltext Hämta fulltext Hämta fulltext

Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs av Isaacs, John D, Burmester, Gerd R

Hämta fulltext Hämta fulltext Hämta fulltext

“Living a normal life”: a qualitative study of patients’ views of medication withdrawal in rheumatoid arthritis av Baker, Kenneth F., Isaacs, John D., Thompson, Ben

Hämta fulltext Hämta fulltext Hämta fulltext

Current concepts in the pathogenesis of early rheumatoid arthritis av Pratt, Arthur G., Isaacs, John D., Mattey, Derek L.

Hämta fulltext Hämta fulltext Hämta fulltext

Basic Mechanisms of JAK Inhibition av Lin, Chung MA, Cooles, Faye AH, Isaacs, John D.

Hämta fulltext Hämta fulltext Hämta fulltext

Ovarian Endometriomas Do Not Adversely Affect Pregnancy Success Following Treatment With In Vitro Fertilization av Isaacs, John D., Hines, Randall S., Sopelak, Victoria M., Cowan, Bryan D.

Hämta fulltext Hämta fulltext Hämta fulltext

Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis av Isaacs, John D, Harari, Olivier, Kobold, Uwe, Lee, Janet S, Bernasconi, Corrado

Hämta fulltext Hämta fulltext Hämta fulltext

Emerging immunotherapies for rheumatoid arthritis av Reynolds, Gary, Cooles, Faye AH, Isaacs, John D, Hilkens, Catharien MU

Hämta fulltext Hämta fulltext Hämta fulltext

What can rheumatologists learn from translational cancer therapy? av Sherlock, Jonathan P, Filer, Andrew D, Isaacs, John D, Buckley, Christopher D

Hämta fulltext Hämta fulltext Hämta fulltext

Drug breakthrough offers hope to arthritis sufferers: qualitative analysis of medical research in UK newspapers av Hanson, Helen, O'Brien, Nicola, Whybrow, Paul, Isaacs, John D, Rapley, Tim

Hämta fulltext Hämta fulltext Hämta fulltext

Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis av Harry, Rachel A, Anderson, Amy E, Isaacs, John D, Hilkens, Catharien M U

Hämta fulltext Hämta fulltext Hämta fulltext

Tolerogenic dendritic cells differentially modulate naïve and memory CD4(+ )T cells av Anderson, Amy E, Sayers, Bethan, Diboll, Julie, Isaacs, John D, Hilkens, Catharien MU

Hämta fulltext Hämta fulltext

Predicting persistent inflammatory arthritis amongst early arthritis clinic patients in the UK: is musculoskeletal ultrasound required? av Pratt, Arthur G, Lorenzi, Alice R, Wilson, Gill, Platt, Philip N, Isaacs, John D

Hämta fulltext Hämta fulltext Hämta fulltext

Components of treatment delay in rheumatoid arthritis differ according to autoantibody status: validation of a single-centre observation using national audit data av Pratt, Arthur G., Lendrem, Dennis, Hargreaves, Ben, Aslam, Osman, Galloway, James B., Isaacs, John D.

Hämta fulltext Hämta fulltext Hämta fulltext

Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents av Strand, Vibeke, Gonçalves, Joao, Hickling, Timothy P., Jones, Heather E., Marshall, Lisa, Isaacs, John D.

Hämta fulltext Hämta fulltext Hämta fulltext

Correction to: Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents av Strand, Vibeke, Gonçalves, Joao, Hickling, Timothy P., Jones, Heather E., Marshall, Lisa, Isaacs, John D.

Hämta fulltext Hämta fulltext Hämta fulltext

Predictors of poor function in RA based on two prospective UK inception cohorts. Do comorbidities matter? av Busby, Amanda D, Wason, James, Pratt, Arthur G, Young, Adam, Isaacs, John D, Nikiphorou, Elena

Hämta fulltext Hämta fulltext Hämta fulltext

Lack of association between clinical and ultrasound measures of disease activity in rheumatoid arthritis remission av Baker, Kenneth F., Thompson, Ben, Lendrem, Dennis W., Scadeng, Adam, Pratt, Arthur G., Isaacs, John D.

Hämta fulltext Hämta fulltext Hämta fulltext

Integrated safety in tocilizumab clinical trials av Schiff, Michael H, Kremer, Joel M, Jahreis, Angelika, Vernon, Emma, Isaacs, John D, van Vollenhoven, Ronald F

Hämta fulltext Hämta fulltext Hämta fulltext